Trial Profile
A Study to Evaluate Whether Treatment Modification of Initial Antiretroviral Therapy (ART) with Recently Approved Drugs Lead to Changes in Adherence and Discontinuation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Dolutegravir (Primary) ; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 03 Mar 2016 New trial record